ADMA: ADMA Biologics Inc

ADMA新闻

• 17:00 Adma Biologics (ADMA) Upgraded to Strong Buy: Here's Why
• 14:30 Wall Street Analysts Think Adma Biologics (ADMA) Is a Good Investment: Is It?
• 16:40 Alkermes Down Despite Q4 Earnings Beat, Announces Leadership Change
• 15:54 ADMA Q4 EPS Up 14% Y/Y, Revenues Gain From Strong Asceniv Performance
• 15:50 Mirum's Q4 Earnings Lag, Higher Product Sales Drive Y/Y Revenues
• 00:14 ADMA Biologics Q4 每股收益 超出预期, 营收 低于预期
• 00:14 ADMA Biologics Inc earnings beat by $0.03, revenue fell short of estimates
• 19:47 ADMA Biologics即将公布财报:能否实现高目标?
• 22:45 Adma Biologics (ADMA) Ascends While Market Falls: Some Facts to Note
• 15:39 Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026?
• 02:57 Adma Biologics总裁Adam Grossman出售价值337,679美元的股票
• 02:55 Adam Grossman, president of Adma Biologics, sells $337,679 in shares
• 15:01 Novocure Gains FDA Approval for Optune Pax to Treat Pancreatic Cancer
• 13:59 NeoGenomics Announces Launch of New Cancer Assay PanTracer Pro
• 22:45 Adma Biologics (ADMA) Registers a Bigger Fall Than the Market: Important Facts to Note
• 22:50 Adma Biologics (ADMA) Exceeds Market Returns: Some Facts to Consider
• 14:30 Is It Worth Investing in Adma Biologics (ADMA) Based on Wall Street's Bullish Views?
• 22:50 Adma Biologics (ADMA) Outpaces Stock Market Gains: What You Should Know
• 14:13 ADMA Gains 13.8% in Three Months: More Upside Potential for 2026?
• 23:00 Adma Biologics (ADMA) Increases Despite Market Slip: Here's What You Need to Know
• 22:50 Adma Biologics (ADMA) Sees a More Significant Dip Than Broader Market: Some Facts to Know
• 18:28 ADMA Biologics Reports Preliminary 2025 Results, Ups 2026 Outlook
• 14:30 Is Adma Biologics (ADMA) a Buy as Wall Street Analysts Look Optimistic?
• 21:16 ADMA Biologics, Inc. (ADMA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript